Homeβ€ΊSearchβ€ΊBritish Journal of Cancer

British Journal of Cancer

Springer Nature Β· United Kingdom Β· Est. 1947

ISSN1532-1827
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJR
96
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (3 more)+18
Total96
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
235
days submission β†’ published
measured Β· last 17 articles Β· accept 212d
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
2.803
H-Indexi
344
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
1.827
Total Worksi
28,492
Total Citationsi
1,544,888
2yr Mean Citednessi
5.53
Open Impact Factor alternative
Retractions
13
Source: Retraction Watch

Aims & Scope

The British Journal of Cancer (BJC) is one of the most cited general cancer journals, it is committed to publishing cutting edge discovery, translational and clinical cancer research. The BJC aims to provide a global platform to disseminate important research within the broad spectrum of oncology. The journal welcomes research across all cancer types and has a focus on: metastasis, microenvironment, immunology and immunotherapy, targeted and next-generation therapeutics, chemotherapy and radiotherapy, mechanisms of resistance, clinical trials, genomics, epigenomics and precision medicine, epidemiology, metabolism and state-of-the art diagnostic approaches.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1947
FrequencyBiweekly
StatusActive (last: 2026)
Total Publications28,492
Publisher OrgSpringer Nature
Visit Journal Website

Submission Info

Peer ReviewPeer Review
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes

Think.Check.Submit Compliance

8/12 Β· 67%
βœ…
Do you know the journal / publisher?
Springer Nature
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1532-1827
βœ…
Indexed in a trusted database?
WoS, Scopus, PubMed
βœ…
Peer review process documented?
Peer Review
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
βœ…
Plagiarism detection in place?
Yes
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
341
21k
2019
517
30k
2020
461
17k
2021
446
13k
2022
420
8.6k
2023
388
4.7k
2024
377
1.2k
2025
210
54
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Cancer ResearchQ1
OncologyQ1

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Cancer ResearchOncology

Research Topics (OpenAlex)

Global Cancer Incidence and ScreeningCancer, Hypoxia, and MetabolismBreast Cancer Treatment StudiesCancer Cells and MetastasisLung Cancer Treatments and MutationsCancer Genomics and DiagnosticsColorectal Cancer Treatments and StudiesCancer-related Molecular PathwaysEstrogen and related hormone effectsImmunotherapy and Immune Responses

Frequently asked questions about British Journal of Cancer

Is British Journal of Cancer a predatory journal?

PubScope has no integrity flags on record for British Journal of Cancer: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of British Journal of Cancer?

British Journal of Cancer is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 5.53.

Is British Journal of Cancer indexed in Scopus and Web of Science?

British Journal of Cancer is indexed in Web of Science, Scopus.

What is the aims and scope of British Journal of Cancer?

The British Journal of Cancer (BJC) is one of the most cited general cancer journals, it is committed to publishing cutting edge discovery, translational and clinical cancer research. The BJC aims to provide a global platform to disseminate important research within the broad spectrum of oncology. The journal welcomes research across all cancer types and has a focus on: metastasis, microenvironment, immunology and immunotherapy, targeted and next-generation therapeutics, chemotherapy and radiotherapy, mechanisms of resistance, clinical trials, genomics, epigenomics and precision medicine, epid

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref